Exact Sciences accounts for an estimated $6 billion to $7 billion of Wisconsin's gross domestic product – as much as roughly ...

Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now. On March 23, the company announced ...

Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...

The deal brings Exact Sciences' flagship screening test for colorectal cancer, Cologuard, under Abbott's umbrella.

Abbott (NYSE:ABT) announced today that it completed its acquisition of cancer diagnostics developer Exact Sciences.

Exact Sciences Corp. chief Kevin T. Conroy explains what it takes to get investors to say yes. Photo: Jennifer Weiss for The ...

Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences ...

Abbott said it has received all regulatory clearances necessary to buy the cancer screening firm.

Abbott (NYSE: ABT) announced today that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026.

For a third consecutive year, a deal involving a health care-focused company is among the state’s largest mergers and ...

Under the collab, Walgreens customers will be able to access tools and resources to better understand their colorectal cancer ...

Astroline revises its content guidelines, emphasizing astrology’s role in self-reflection and clarifying its non-scientific, non-predictive nature. CA, UNITED ...